Survival of chronic hemodialysis patients over 80 years of age

Branka Sladoje-Martinovic1, Ivana Mikolasevic1, Ivan Bubic1

  • 1Department of Nephrology and Dialysis, Division of Internal Medicine, University Hospital Center Rijeka, Rijeka, Croatia.

Insights

Survival rates for elderly patients over 80 starting hemodialysis (HD) improve with planned care, good nutrition, and arteriovenous fistula access. These factors are crucial for managing chronic kidney disease (CKD) in this growing population.

Area of Science:

  • Nephrology
  • Geriatrics
  • Internal Medicine

Background:

  • The incidence of end-stage renal disease requiring hemodialysis (HD) is increasing in patients aged 80 and older.
  • This demographic shift necessitates a deeper understanding of survival factors in very elderly individuals undergoing HD treatment.

Purpose of the Study:

  • To analyze the trends in new patients aged 80+ starting HD.
  • To determine the survival rates of this patient group.
  • To identify key variables independently associated with survival in very elderly HD patients.

Main Methods:

  • A single-center, retrospective cohort study was conducted from January 1987 to September 2012.
  • The study included 78 patients aged 80 years or older at the initiation of HD.
  • Survival analysis and identification of mortality-associated factors were performed.

Main Results:

  • The number of new HD patients aged 80+ increased significantly since 2003.
  • Mean survival was 25.1 months; 30.8% survived less than 12 months, while 9% survived over 60 months.
  • Poor survival was linked to high C-reactive protein, poor nutritional status, lack of pre-HD nephrology care, and catheter vascular access.

Conclusions:

  • Optimal survival in very elderly HD patients is associated with pre-dialysis nephrology care and planned management.
  • Good nutritional status and arteriovenous fistula as vascular access at HD initiation are critical for better outcomes.
  • Cardiovascular disease was the leading cause of death in approximately half of the patients.
Abstract

Related Concept Videos

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
266
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
245
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
239
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
203
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
193
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
1.6K